Thomas R, Beer R, Harris B, John R, Scanlon M
Department of Psychological Medicine, University of Wales, College of Medicine, Cardiff, U.K.
J Affect Disord. 1989 Mar-Jun;16(2-3):133-7. doi: 10.1016/0165-0327(89)90067-0.
The growth hormone (GH), thyrotrophin (TSH) and prolactin response to growth hormone releasing factor (GRF) was investigated in 18 patients suffering from major depression with melancholia and in 18 age- and sex-matched normal controls. There was no significant difference in the GH response to GRF stimulation between the patients and controls and in neither subject group was there a demonstrable TSH or prolactin response to GRF. These findings indicate that the pathophysiology underlying the blunted GH response to pharmacological challenge, demonstrated in other studies, must lie at a suprapituitary level.